1h Free Analyst Time
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Artificial Intelligence (AI) Market ReportSpeak directly to the analyst to clarify any post sales queries you may have.
The healthcare artificial intelligence market is expected to reach USD 44.5 billion by 2026, growing at a CAGR of 46.21%.
Several pharmaceutical companies are implementing innovative technologies to boost their growth in the global healthcare industry. Collaboration of GSK with Exscientia identified a small compound for targeted therapeutics and its characteristics towards the specific target using the AI platform. AI is becoming an incredible platform in the pharmaceutical industry. For instance, Novartis announced Microsoft as a strategic partner in AI and data science to set up an AI innovation lab. Since the last year, over 50+ companies have got machine learning and AI algorithms approvals. During the COVID-19 pandemic, AI played a significant role in the healthcare industry. An analytics study by Accenture combined with clinical applications demonstrated the potential of AI to reduce approximately USD 150 billion per annum by 2026 in the US healthcare system.
The following factors are likely to contribute to the growth of the healthcare artificial intelligence market during the forecast period:
- Increase in patient volume & complexities associated with data fueling demand for AI.
- The shrinking operational workforce in healthcare facilities propelling the need for AI.
- Technological advancement & innovations in AI influencing end-users in the market.
- Rising Investment in advanced drug discovery & development process augmenting the adoption of AI.
KEY HIGHLIGHTS
- The healthcare providers segment accounted for the largest market share with around 48% compared to others in 2020.
- According to the research, the publisher estimated that APAC would witness the highest growth in the healthcare artificial intelligence (AI) market during the forecast period.
The study considers a detailed scenario of the present healthcare artificial intelligence market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTATION
This research report includes a detailed segmentation by
- Category
- Application
- Technology
- End-user
- Geography
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTS
The software industry provides numerous services to the healthcare industry. With the advent of medical software, human errors are minimized in the global medical market. Using advanced software in healthcare enables the clinical experts to expertise their practices. Software providers are gaining huge opportunities in the healthcare artificial intelligence (AI) market. Software development companies are constantly striving to improve the industry and bring innovations.
Market Segmentation by Application
- Hospital Workflow Management
- Medical Imaging and Diagnosis
- Drug Discovery and Precision Medicine
- Patient Management
Market Segmentation by Technology
- Machine Learning
- Querying Method
- Natural Language Processing
- Others
Market Segmentation by End-users
- Healthcare Providers
- Pharma-biotech and medical devices companies
- Payers
- Others
GEOGRAPHICAL ANALYSIS
US is the major revenue generator of the healthcare artificial intelligence (AI) market across the North American region. In North America, the potential increase in AI GDP is compounded by tremendous opportunities to adopt more productive technologies.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Nordic Countries
- APAC
- China
- India
- Japan, Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
- UAE
VENDOR ANALYSIS
Giant players are focusing on pursuing organic growth strategies to enhance their product portfolio in the healthcare artificial intelligence (AI) market. Several initiatives by the players will complement growth strategies, which are gaining traction among end-users in the market. Rising growth of startups collaborating with key vendors in promoting their artificial intelligence in healthcare applications creating heavy competition in the market.
Prominent Vendors
- IBM (International Business Machines)
- Intel Corporation
- Medtronic
- Microsoft Corporation
- Nvidia Corporation
- Siemens Healthineers
Other Prominent Vendors
- Arterys
- Caption Health
- Enlitic
- Catalia Health
- General Vision
- Philips
- Stryker
- Shimadzu Recursion Pharmaceuticals
- GE Healthcare
- Remedy Medical
- Subtle Medical
- Netbase Quid
- Biosymetrics
- Sensely
- InformAI
- Bioclinica
- Owkin
- Binah.AI
- Oncora Medical
- Qure.AI Technologies
- Lunit
- Caresyntax
- Anju software
- Imagia Cybernetics
- Deep Genomics
- Welltok Inc.
- MDLive
- MaxQ AI
- Qventus
- Workfusion
KEY QUESTIONS ANSWERED:
1. How big is the healthcare artificial intelligence (AI) market?
2. Which region has the highest share in the healthcare artificial intelligence market?
3. Who are the key players in the healthcare AI market?
4. What are the latest market trends in the healthcare artificial intelligence market?
5. What is the use of AI in the healthcare market?
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market At A Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Restraints
11 Market Landscape
12 Component
13 Application
14 Technology
15 End-User
16 Geography
17 North America
18 Europe
19 APAC
20 Latin America
21 Middle East & Africa
22 Competitive Landscape
23 Key Company Profiles
24 Other Prominent Vendors
25 Report Summary
26 Quantitative Summary
27 Appendix
LIST OF EXHIBITS
LIST OF TABLES
Companies Mentioned
- IBM (International Business Machines)
- Intel Corporation
- Medtronic
- Microsoft Corporation
- Nvidia Corporation
- Siemens Healthineers
- Arterys
- Caption Health
- Enlitic
- Catalia Health
- General Vision
- Philips
- Stryker
- Shimadzu Recursion Pharmaceuticals
- GE Healthcare
- Remedy Medical
- Subtle Medical
- Netbase Quid
- Biosymetrics
- Sensely
- InformAI
- Bioclinica
- Owkin
- Binah.AI
- Oncora Medical
- Qure.AI Technologies
- Lunit
- Caresyntax
- Anju software
- Imagia Cybernetics
- Deep Genomics
- Welltok Inc.
- MDLive
- MaxQ AI
- Qventus
- Workfusion
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
